Introduction :
Diabetic nephropathy is characterized by persistent albuminuria, a relentless decline in glomerular filtration rate (GFR), raised arterial pressure and increased relative mortality for cardiovascular diseases. 1 Diabetic nephropathy ( DN) is one of those complications which has a prevalence of 7% to 21% reported in different studies conducted in Asia 2 .
The prevalence of DN in Bangladesh is 17.9% among those who are diabetic for >10 years 3 . It is the leading cause of End-stage Renal Disease (ESRD) requiring dialysis in developed countries 5 and it is the second common cause of ESRD in Bangladesh. 6 Chronic dialysis treatment obviously decreases the quality of life and creates tremendous financial responsibility for the patient and society. So, it is very much essential to detect renal involvement at an early stage and to prevent, or at least retard, the progression of renal insufficiency.
The raised blood pressure is an important factor in the progression of renal disease in diabetes, even from the initial phase of the slight elevation of the albumin excretion rate. There is a significant correlation between blood pressure and the progression of albuminuria in both type 1 and type 2 diabetes. 22 Microalbuminuria predicts the development of diabetic nephropathy and increase blood pressure contributes to the progression of nephropathy in type 1 diabetes. 7 Also in type 2 diabetes it is predictive of clinical proteinuria and increase mortality. 8 Diabetic nephropathy occurs only in a subset of diabetic patients, approximately 30 to 4o percent in type 1 diabetes and 30 percent in type 2 diabetes of more than 10 years of duration. 9, 10 Why only one third of diabetic patients develop nephropathy can not be explained solely by differences of glycemic control. 11 Hypertension in patients with type 1 diabetes develops mainly in those who are proteinuric. Those who do not develop nephropathy remain normotensive despite longer duration of diabetes and advancing age. 30, 31 Familial clustering of diabetic nephropathy has been reported in type 1 diabetes. 12 A genetic influence of the development of nephropathy has similarly been described in Pima Indians with type 2 diabetes. 13 These observations suggest that genetic factors are involved in the susceptibility to develop hypertension and diabetic nephropathy. The diabetic subjects were studied by dividing them into several groups in the following way:
Based on family history of hypertension: a) Diabetes with family history of hypertension, FH (+)ve group. b) Diabetes without family history of hypertension, FH (-)ve group.
Based on presence or absence of hypertension: a) Diabetes with hypertension, hypertensive group. b) Diabetes without hypertension, normotensive group.
Based on presence or absence of microalbuminuria: a) Diabetes with microalbuminuria, microalbuminuric group. b) Diabetes without microalbuminuria, normomicroalbuminuric group.
Medical histories of the patients were taken carefully. Clinical parameters (age, sex, body mass index (BMI), blood pressure and family history of hypertension ) were recorded in a predesigned data sheet for the study. Blood pressure was measured into two consecutive office visits in a sitting position after a 5-10 min rest by sphygmomanometer. The median value of the two visit readings was used for classifying patients into two groups according to WHO criteria. A positive family history of hypertension if one or both parents had been diagnosed hypertensive or were undergoing treatment for hypertension.
Specific laboratory investigations (blood glucose fasting and 2 hours post glucose load, serum urea, serum creatinine, albumin creatinine ratio (ACR) were done in each patient. Biochemical parameters were recorded in a predesigned data for the study.
Serum glucose was measured by glucose-oxidase method. serum urea, serum creatinine, and urinary creatinine were measured by enzymatic colorimetric methods. Urinary albumin (microalbuminuria) was measured by immunoturbidimetry method.
First voided morning urine samples were collected in a clean test tube and centrifuged at a rate of 3000 rpm for 10 minutes. 1.5 ml of clear urine sample was transferred into amicrocentrifuge tube preserved at -70 0 C in the freezer for analysis of urinary creatinine by alkaline picrate method and urinary albumin was estimated by immunoturbidimetry method. Another test tube containing urine was used for routine microscopic examination immediately.
Albumin creatinine ratio (ACR) was calculated from urinary creatinine and urinary albumin. Microalbuminuria (MA) was labeled in a patients when in first morning urine sample, albumin-creatinine ratio (ACR) was greater than mean±2SD (two standard deviation) ACR of Control subjects. An ACR of 2.0 -2.5 mg/mmol to 20-35 mg/mmol corresponds to albumin excretion of 20 -200 µg/min or 30 -300 mg/day. 27, 28, 29 In this study control subjects mean±2SD of urinary albumin creatinine ratio (ACR) was 2.77 mg/mmol. ACR 2.77mg/mmol was taken as a cut-off value. Diabetic subjects with ACR < 2.77 mg/mmol was designated as normoalbuminuric and subject with ACR > 2.77 mg/mmol was designated as microalbuminuric.
Statistical Analysis :
All variables are expressed as mean±SD unless otherwise stated. Albumin creatinine ratio (ACR), Serum triglyceride, C-peptide levels are expressed as median ( range ). The comparison between the groups was made either by unpaired Student , s t-test or Mann-Whitney U test as required by using SPSS windows package 12.0 version and p value below 0.05 was considered significant.
Results :
Fourty six diabetic normotensive subjects were match for age, BMI, glycaemic status and renal function tests with seventeen diabetic hypertensive subjects and were studied for microalbuminuria. Comparison of microalbuminuria was found no significant difference in diabetic normotensive and diabetic hypertensive subjects [median (range) 1.67 (0.17-8.62) vs 1.70 (0.28-9.43) mg/mmol, p= NS]. (Table I) Thirty seven diabetic subjects with family history of hypertension FH (+)ve group were matched with twenty six diabetic subjects without family history of hypertension FH (-)ve group and were studied for systolic blood pressure, diastolic blood pressure and microalbuminuria. The systolic blood pressure, diastolic blood pressure and microalbuminuria were significantly higher in FH (+)ve group than FH (-)ve group. (Table III) 
Discussion :
In this study population, the prevalence of hypertension is 40% in diabetics with family history of hypertension and 7.7% in diabetics without family history of hypertension. This finding is consistent with other studies in the similar populalation. 14, 32 To see the relation of hypertension with microalbuminuria, the diabetic hypertensive subjects were matched for age, BMI, blood glucose and renal function tests with Diabetic normotensive subjects studied for albumin creatinine ratio (ACR) or microalbuminuria. No significant difference in microalbuminuria was found between diabetic hypertensive and diabetic normotensive subjects. This result was similar with the other study in the Bangladeshi population. 14 In this study population, the prevalence of microalbuminuria is 30%. This finding is consistent with other studies in the Bangladeshi population. The incidence of microalbuminuria was 37% in another study with newly detected, untreated type 2 diabetic subjects. 14 Three previous studies on young onset (under 30 years) type 2 diabetic subjects of Bangladeshi population also showed similar results. 15, 16, 17 When diabetic microalbuminuric subjects were matched for age, BMI, blood glucose, lipid profile and renal function tests with diabetic normoalbuminuric subjects and studied for blood pressure . No significant difference in blood pressure was found between diabetic normoalbuminuric and diabetic microalbuminuric subjects. Hada and Iqbal also found similar results in type 2 diabetic subjects in the similar population. 17, 14 Contrary to this, increased blood pressure has been reported in type 1 diabetic patients with microalbuminuria. 18, 19 But there is some controversy as to whether the elevated arterial pressure precedes the development of microalbuminuria in type 1 diabetes or it occurs after its development. 20 Microalbuminuria is related with blood pressure and known duration of diabetes. 21 Systolic blood pressure has been found to be a determinant of microalbuminuria in type 2 diabetes. 21 Nevertheless, from the earliest phase of microalbuminuria, blood pressure tends to increase by an average of 3 to 4 mmHg per year compared with 1mmHg per year in long term normoalbuminuria in type 1 diabetic patients and healthy controls. 22 But the absolute level of blood pressure in patients with microalbuminuria often within the conventional normotension. 23 To observe the possible genetic influence of family history of hypertension on the raised arterial pressure and albumin creatinine ratio (ACR) or microalbuminuria; diabetic subjects with family history of hypertension (FH + ve group) was matched for age, BMI, glycaemic status and renal function tests with diabetic subjects without family history of hypertension ( FH -ve group) and were studied for systolic blood pressure, diastolic blood pressure and microalbuminuria. The systolic blood pressure, diastolic blood pressure and microalbuminuria were significantly higher in FH (+)ve group than FH (-)ve group. This result is supported by many of the literatures that the familial predisposition to hypertension contributing to the susceptibility to diabetic nephropathy and raised arterial pressure. 24, 11 The association of microalbuminuria and raised arterial pressure with family history of hypertension raise the possibility that the genetics of essential hypertension and diabetic nephropathy may partially overlap. Thus any candidate gene proposed for essential hypertension can also be considered as a susceptibility gene for diabetic nephropathy. 25 Therefore familial predisposition to hypertension can identify a subgroup of type 2 diabetic subjects who are prone to develop microalbuminuria and raised arterial pressure in diabetic population irrespective of presence or absence of hypertension and diabetic nephropathy.
